EMEA-002484-PIP01-18

Table of contents

Key facts

Active substance
2-[[8-chloro-3-[(4-chlorophenyl)methyl]-4-(difluoromethoxy)-2-ethyl-5-quinolinyl]oxy]acetic acid Llysine salt (GB001)
Therapeutic area
Pneumology-allergology
Decision number
P/0051/2020
PIP number
EMEA-002484-PIP01-18
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral solid dosage form
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Oral use
Contact for public enquiries
GB001, Inc.

Tel. +1 8586841327
E-mail: jspinella@gossamerbio.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating